Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

Share Price is delayed by 15 minutes
Get Live Data
27.00    0.00 (0.00%)
Bid:
26.50
Ask:
27.50
Spread: 1.00 (3.774%)
Market Cap: £135.95m
DUKE Live PriceLast checked at - London Stock Exchange

Intraday Duke Capital Share Chart

Trading Update

3 Mar 2023 07:00

RNS Number : 7456R
Duke Royalty Limited
03 March 2023
 

3 March 2023

Duke Royalty Limited

("Duke Royalty", "Duke" or the "Company")

Trading Update

 

Duke Royalty, a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and North America, is pleased to provide the following trading and operational update for the business for its third financial quarter ending 31 December 2022 ("Q3 FY23") as well as guidance on trading for its fourth financial quarter ending 31 March 2023 ("Q4 FY23").

 

Based on current trading, Duke expects to achieve recurring cash revenue* of £5.7 million in Q4 FY23. This represents a 21% year on year increase (Q4 FY22: £4.7 million) and an increase on the prior quarter, Q3 FY23, which saw the Company deliver record recurring cash revenue of £5.6 million.

Overview of quarterly revenue growth:

 

Recurring Cash Revenue

Total Cash Revenue**

Q3 FY22

£3.9 million

£3.9 million

Q4 FY22

£4.7 million

£6.7 million

Q1 FY23

£5.1 million

£5.1 million

Q2 FY23

£5.3 million

£5.3 million

Q3 FY23

£5.6 million

£5.6 million

 

* Recurring cash revenue excludes buyback premium receipts and cash gains from equity sales

** Total cash revenue is monthly cash distributions from Duke's royalty partners plus cash gains received from the sales of equity assets and buyback premiums

 

Highlights:

· During the quarter, Duke was pleased to announce the refinanced and upsized credit facility, on improved terms, with Fairfax Financial Holdings Limited. The new credit facility is a 225 bps improvement in cost. The new credit facility is for up to £100 million and replaced Duke's previous £55 million term and revolving facilities.

· Also during Q3 FY23, Duke completed a new £5.0 million royalty investment into New Path Fire & Security ("NPFS"), a growing and acquisitive platform, buying independent regional fire safety and security companies across southern England. NPFS predominantly serves business customers, helping them to protect their premises, assets, and most importantly their people. Alongside the royalty investment, Duke invested £0.5 million to acquire a 15 per cent equity stake in NPFS.

· Duke also provided further financing to specialist residential and domiciliary care provider, Tristone Healthcare Limited. Duke committed £3.2 million to fund the acquisition of K Bond Healthcare Limited, a well-respected residential and nursing care provider with operations across Greater Manchester. The financing increases Duke's total investment into Tristone to £17.6 million.

Neil Johnson, CEO of Duke Royalty, said:

"These strong results follow the addition of another royalty partner in New Path Fire & Security to our portfolio, as well a follow-on investment into social care platform Tristone Healthcare during the period. Our increasing recurring cash revenues also reflect the good performance of our partners despite the headlines of economic headwinds and inflation worries.

"With Fairfax Financial as our new senior lender, we have a world class partner to continue our growth. As we look ahead to Duke's 2024 financial year, we believe we have a solid foundation to continue to grow the business and add royalty partners to continue revenue growth and portfolio diversification."

 

***ENDS***

 

For further information, please visit www.dukeroyalty.com or contact:

 

 

Duke Royalty Limited

Neil Johnson / Charles Cannon Brookes / Hugo Evans

 

 

+44 (0) 1481 730 613

Cenkos Securities plc 

(Nominated Adviser

and Joint Broker)

 

Stephen Keys / Callum Davidson / Michael Johnson

 

+44 (0) 207 397 8900

 

Canaccord Genuity

(Joint Broker)

 

Adam James / Harry Rees

+44 (0) 207 523 8000

SEC Newgate (PR)

Elisabeth Cowell / Matthew Elliott

+44 (0) 20 3757 6882 dukeroyalty@secnewgate.co.uk

 

About Duke Royalty

 

Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFFIVVIIFIIV
Date   Source Headline
18th Jun 20207:00 amRNSFollow-on contribution to royalty partner
17th Jun 20207:01 amRNSDividend Declaration
17th Jun 20207:00 amRNSIssue of Equity
14th May 20202:05 pmRNSSecond Price Monitoring Extn
14th May 20202:00 pmRNSPrice Monitoring Extension
14th May 20207:00 amRNSTrading and Dividend Update
6th May 20204:42 pmRNSSecond Price Monitoring Extn
6th May 20204:36 pmRNSPrice Monitoring Extension
5th May 20204:45 pmRNSHolding(s) in Company
2nd Apr 20207:00 amRNSTrading Update re: COVID-19
16th Mar 20204:41 pmRNSSecond Price Monitoring Extn
16th Mar 20204:35 pmRNSPrice Monitoring Extension
16th Mar 20207:00 amRNSFollow-on contribution to royalty partner
11th Mar 20207:01 amRNSDividend Declaration & Trading Update
11th Mar 20207:00 amRNSDirectorate Change
30th Jan 20207:00 amRNSFollow-on contribution to royalty partner
23rd Jan 202012:35 pmRNSHolding(s) in Company
13th Jan 20207:00 amRNSPortfolio Update
9th Jan 20205:23 pmRNSHolding(s) in Company
9th Jan 20205:20 pmRNSHolding(s) in Company
16th Dec 20197:00 amRNSDividend Declaration
6th Dec 20197:01 amRNSLong Term Incentive Plan Awards
6th Dec 20197:00 amRNSInterim Results
4th Nov 20197:00 amRNSPaydown of Revolving Credit Facility
1st Nov 20197:00 amRNSFollow-on contribution to royalty partner
31st Oct 20193:19 pmRNSDirectors' Dealings
30th Oct 20191:55 pmRNSResult of EGM and Issue of £17.5 million of Equity
25th Oct 20197:00 amRNSNotification of major holdings
16th Oct 201911:26 amRNSResult of Annual General Meeting
7th Oct 20197:00 amRNSResult of Retail Offer and Open Offer Details
4th Oct 20194:31 pmRNSRetail Offer via PrimaryBid.com
4th Oct 20194:30 pmRNSFundraising of up to £20 million
19th Sep 20197:00 amRNSIncreased Interim Dividend & Dividend Declaration
18th Sep 20197:00 amRNSPosting of Report & Accounts and Notice of AGM
10th Sep 20197:00 amRNSIncreased £30M Credit Facility on Improved Terms
9th Sep 20197:00 amRNSFiscal 2019 Final Results
29th Aug 20197:00 amRNSFollow-On Contribution and Restructuring
14th Aug 20197:00 amRNSUpdate and Notice of Results
25th Jul 20195:51 pmRNSNotification of major holdings
19th Jun 20197:00 amRNSDividend Declaration
28th May 20197:00 amRNSFollow-on contribution to royalty partner
14th May 20191:00 pmRNSModification of Partners' Agreements - Amendment
14th May 20197:00 amRNSModification of Partners' Agreements
7th May 20197:00 amRNSNotification of major holdings
22nd Mar 20197:00 amRNSDirector's Dealings
19th Mar 20197:00 amRNSDividend Declaration
14th Mar 20197:00 amRNSChange of Adviser
19th Feb 20197:00 amRNSNew Royalty Finance Agreement
5th Feb 20191:50 pmRNSHolding(s) in Company
4th Feb 20197:00 amRNSAcquisition of UK royalty finance provider

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.